Another knock down paper from South Africa! This time 501Y.V2 (B.1.351) is giving again good news with confirming that neutralise other lineages but also another VOC, the P1.
We observed no significant difference in the magnitude of binding (Figure 1A) or neutralizing (Figure 1B) responses between the 501Y.V2 cohort and the wave 1 (i.e. B.1 original lineages) admission samples.
Plasma binding antibodies in 501Y.V2 infected individuals are cross-reactive.
Probably, the most important results is how the 501Y.V2 neutralise well the D601G original lineages but stronger the P1 variant... It points to a direction that 501Y.V2 may cross neutralise to other variants of concerns (VOCs).